Author： Steiner T. Junker K. Burkhardt F. Braunsdorf A. Janitzky V. Schubert J.
Publisher： Elsevier
ISSN： 0302-2838
Source： European Urology, Vol.41, Iss.2, 2002-02, pp. : 167-171
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
8p22> loss concurrent with 8c gain is associated with poor outcome in prostate cancer
By Macoska J.A. Trybus T.M. Wojno K.J.
Urology, Vol. 55, Iss. 5, 2000-05 ,pp. :
Access to resources
Recommend
By de la Taille A. Zerbib M. Conquy S. Amsellem-Ouazana D. Thiounn N. Flam T. Saighi D. Debre B.
European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. :
Hormonal therapy for prostate cancer: primum non nocere
By Milbank A.J. Dreicer R. Klein E.A.
Urology, Vol. 60, Iss. 5, 2002-11 ,pp. :
By Ozen M. Hopwood V.L. Johnston D.A. Babaian R.J. Logothetis C.J. von Eschenbach A.C. Pathak S.
Urology, Vol. 53, Iss. 2, 1999-02 ,pp. :